Table 3.
Current postmenopausal hormone use and odds of incident incontinencea from 2001 to 2003
| Postmenopausal hormone use | Non-cases | Cases | Age-adjusted OR (95% CI) | Multivariable-adjustedb OR (95% CI) |
|---|---|---|---|---|
| Never | 1,568 | 211 | 1.00 | 1.00 |
| Current, type of hormone | ||||
| Oral estrogen alone | 1,417 | 287 | 1.51 (1.24–1.83) | 1.35 (1.03–1.78) |
| Oral estrogen and progestin | 1,538 | 268 | 1.29 (1.06–1.57) | 1.37 (1.13–1.67) |
| Transdermal estrogen alone or with progestin | 295 | 61 | 1.53 (1.12–2.09) | 1.41 (0.98–2.01) |
a
Incontinence defined as leaking urine at least once per month
b
Adjusted for age, parity, body mass index, race/ethnicity, cigarette smoking, hysterectomy, oral contraceptive use